URGO URGOSTART INTERFACE 15 CM X 20 CM

Descriptions
Urgo UrgoStart Interface 15 cm x 20 cm is made up of a non-occlusive flexible polyester weave in contact with the wound, derived from TLC-NOSF technology (Lipidocolloid Technology - Nano Oligo Sacharide Factor). It contains vaseline and hydrocolloid particles in its weave, helping to maintain a moist environment conducive to wound healing while ensuring pain-free, atraumatic care for the patient. This oily dressing also allows the passage of exudates, which will be absorbed by a secondary dressing that must be applied as an overlay.

The Urgostart Interface plaster is indicated for the immediate treatment (START) of wounds such as:
- Venous or arterial leg ulcers.
- Pressure sores.
- Diabetic foot sores.
- Acute chronic wounds.

Directions for use
Carefully read the instructions for use before use.
- Preparing the wound: Clean the wound according to the usual care protocol. If an antiseptic has previously been used, rinse the wound thoroughly with saline before applying Urgostart Interface. Dry the peri-injured skin thoroughly. Urgostart Interface can be cut with sterile material to adapt, if necessary the size of the plaster to the wound.
- Applying the plaster: Remove the protective wings. Apply the plaster to the wound. Cover Urgostart Interface with a secondary plaster adapted to the volumes of exudate and hold it in place with a stretch bandage, multi-stretch plaster or tubular mesh. The micro-adherent hydrocellular version of Urgostart Interface (UrgoStart) is also available for exuding wounds.
- Renewal of the plaster: Urgostart Interface is renewed every 2 to 4 days, and can be left in place for up to 7 days depending on the volume of exudate and the clinical condition of the wound. The recommended duration of treatment is a minimum of 8 weeks.

Precautions for use
Urgostart Interface adheres to latex surgical gloves. It is therefore recommended to moisten the gloves with physiological saline to facilitate the handling of Urgostart Interface. In the presence of a wound showing signs of significant bacterial colonisation, it is advisable to first treat the bacterial component before initiating treatment with Urgostart Interface. In the case of an atypical ulcer showing induration or localised excess budding, treatment with Urgostart Interface should only be initiated after checking that the ulcer is not degenerating, so as not to delay diagnosis. In the case of deep, anfractuous or fistulous wounds, leave part of the Urgostart Interface plaster visible and accessible outside the wound. Possible tingling or even painful sensations have been reported mainly at the start of treatment with Urgostart Interface. In relation to the product's activity on the resumption of the scarring process, these rarely justify suspension of treatment. In the absence of clinical data in acute uncomplicated wounds and in the context of Epidermolysis Bullosa regardless of its age, the use of Urgostart Interface is not recommended. Do not resterilise the plaster. This is a single-use plaster: re-use of a single-use plaster may lead to a risk of infection. Store the Urgostart Interface plaster away from moisture and heat.

Contraindications
At the risk of delaying appropriate management: cancerous wounds, fistulous wounds revealing deep abscessation. Do not use Urgostart Interface in case of known sensitivity to the plaster.

Composition
carboxymethylcellulose, vaseline, paraffin, antioxidant, cohesion polymer, wetting agent, micronised oligosaccharide (NOSF), polyurethane foam.

Packaging
16 plasters.